These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1696409)

  • 1. FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions.
    Propper DJ; Woo J; Thomson AW; Catto GR; Macleod AM
    Transplantation; 1990 Aug; 50(2):267-71. PubMed ID: 1696409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of rapamycin on humoral immunity in vivo. Suppression of primary responses but not of ongoing alloantibody synthesis or memory responses.
    Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
    Transplantation; 1992 Dec; 54(6):1058-63. PubMed ID: 1465771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.
    Woo J; Propper DJ; Macleod AM; Thomson AW
    Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A and the humoral response to blood transfusion in the rat: definition of antigens which suppress alloantibody formation.
    Propper DJ; Jones MC; Stewart KN; Catto GR; Power DA
    Clin Sci (Lond); 1991 Jan; 80(1):9-15. PubMed ID: 1846797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloantibody and transferable suppressor activity induced by cyclosporine and blood transfusions in the rat.
    Jones MC; Power DA; Cunningham C; Stewart KN; Catto GR
    Transplantation; 1988 Nov; 46(5):645-9. PubMed ID: 2973667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of repeated transfusions and cyclosporine on secondary alloantibody responses in inbred rats.
    Jones MC; Power DA; Cunningham C; Catto GR
    Transplantation; 1988 Jun; 45(6):1094-9. PubMed ID: 3260048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE; Baldwin WM; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to noninherited maternal RT1A antigens in inbred rats.
    Propper DJ; Woo J; Stewart KN; Catto GR; Power DA
    Transplantation; 1991 Aug; 52(2):331-5. PubMed ID: 1871807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
    Baldwin WM; Rhoton K; Sanfilippo F
    Transplantation; 1991 Feb; 51(2):481-5. PubMed ID: 1994544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cyclosporin A on alloantibody responses in inbred rats: provisional evidence for a serum factor with antiidiotypic activity.
    Cunningham C; Power DA; Stewart KN; Catto GR
    Clin Exp Immunol; 1988 Apr; 72(1):130-5. PubMed ID: 3260835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP; Shittu E; Bell EB
    J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantibody and intragraft cellular response to MHC class I-disparate kidney allografts in recipients tolerized by donor-specific transfusion and cyclosporine.
    Tweedle JR; Middleton SE; Marshall HE; Bradley JA; Bolton EM
    Transplantation; 1996 Jul; 62(1):23-9. PubMed ID: 8693538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose FK 506 inhibits sensitisation after blood transfusions.
    Propper DJ; Woo J; Thomson AW; Catto GR; Macleod AM
    Transplant Proc; 1990 Aug; 22(4):1649-51. PubMed ID: 1697114
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
    Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4Ig inhibits alloantibody responses to repeated blood transfusions.
    Ibrahim S; Jakobs F; Kittur D; Hess A; Linsley PS; Sanfilippo F; Baldwin WM
    Blood; 1996 Dec; 88(12):4594-600. PubMed ID: 8977251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
    Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
    Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
    Yang CP; Shittu E; McManus B; Wood PJ; Bell EB
    Transplantation; 1998 Sep; 66(5):639-45. PubMed ID: 9753346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.